Skip to main content
Clinical Trials/CTRI/2023/08/056587
CTRI/2023/08/056587Not yet recruitingPhase 3

Comparative evaluation of Sub-epithelial connective tissue graft and Xenogenic collagen membrane in the treatment of gingival recession: A Randomised controlled clinical trial. - NI

Shweta Ahlawat0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Systemically healthy subjects with class I (Marginal tissue recession, which does not extend to the mucogingival junction (MGJ)) /II (Marginal tissue recession extending to or beyond mucogingival junction (MGJ) with no radiographic sign of bone loss and requiring surgical intervention for root coverage)
  • 2. Probing pocket depth <3mm
  • 3. No prior history of any surgical procedures on the site to be treated.
  • 4. Presence of detectable CEJ.
  • 5. Not using tobacco in any form.
  • 6. Systemically healthy subjects with no contraindication to periodontal surgery.
  • 7. Able to achieve good oral hygiene.
  • 8. Subjects who gave written consent.
  • 9. Subjects who were available for follow up.

Exclusion Criteria

  • 1. Persistence of uncorrected gingival trauma from tooth brushing.
  • 2. Presence of severe tooth malposition, rotation or clinically significant supraeruption.
  • 3. Cervical or root caries, cervical abrasion, prosthetic crown and restorations involving cemento-enamel junction.
  • 4. Pregnant and lactating mothers.
  • 5. Hypersensitivity or allergy to the collagen based medical products.

Investigators

Sponsor
Shweta Ahlawat

Similar Trials